The reduction of HDL-c and apoA-I concentrations observed in patients with CKD are partly explained by the downregulation of apoA-I synthesis by the liver [15] but also by the defective LCAT concentration and activity, leading to altered plasma HDL remodeling [16]. This evidence concerns the gene APOA1 and chronic kidney disease.